Open AccessAdditional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin
Author(s) -
Kousuke Kubota,
Haruki Uojima,
Xue Shao,
Shuichiro Iwasaki,
Hisashi Hidaka,
Naohisa Wada,
Takahide Nakazawa,
Akitaka Shibuya,
Makoto Kako,
Wasaburo Koizumi
Publication year - 2021
Publication title -
digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.879
H-Index - 66
eISSN - 1421-9875
pISSN - 0257-2753
DOI - 10.1159/000518067
Subject(s) - rifaximin , medicine , gastroenterology , hepatic encephalopathy , group b , randomized controlled trial , carnitine , encephalopathy , cirrhosis , antibiotics , biochemistry , chemistry
Data regarding the additional effect on the recurrence of hepatic encephalopathy (HE) after oral L-carnitine administration are scarce.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom